Table 2

Exposure to nephrotoxic drugs during primary hospitalisation

Characteristic Study group
(n = 31)
Control group
(n = 35)
p value
Cumulative dosage of:
 antenatal indomethacin (mg)500 (100–1645)
 postnatal indomethacin (mg/kg)0.65 (0.37–1.20)
Treatment with netilmycin10066<0.001
 Duration of use (days) 10 (2–34)5 (0–20)0.003
Treatment with cephalosporins61430.212
 Duration of use (days) 6 (0–30)0 (0–19)0.086
Treatment with vancomycin19140.743
 Duration of use (days) 0 (0–18)0 (0–16)0.656
Treatment with furosemide10046<0.001
 Duration of use (days) 6 (1–48)0 (0–15)<0.001
Treatment with spironolactone and hydrochlorothiazide39200.110
 Duration of use (days)0 (0–98)0 (0–51)0.110
  • Categorised data are shown as % and continuous data as median (range).